ReAlta Life Sciences, Inc. has a strong patent portfolio
59 patents and provisional applications, with world-wide coverage
Significant published patents include:
- METHODS FOR REGULATING COMPLEMENT CASCADE PROTEINS USING ASTROVIRUS COAT PROTEIN AND DERIVATIVES THEREOF, patent #8,241,843, issued 2012.
- PEPTIDE COMPOUNDS AND METHODS OF USE, pending 2019
- PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM, patent #8,906,845, issued 2014; patent #9,422,337, issued 2016; patent #9,914,753, issued 2018
- DERIVATIVE PEPTIDE COMPOUNDS AND METHODS OF USE; patent #10,005,818, issued 2018.